C-Rad AB (LTS:0R44) Valuation Rank


LTS:0R44 C-Rad AB LTS:0R44
91 GF Score
Price kr35.90
GF Value kr33.52
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

C-Rad AB Valuation Rank Related Terms

LTS:0R44
91GF Score
C-Rad AB LTS:0R44
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr35.90 is trading 7.1% above its estimated GF Value™ of kr33.52. GuruFocus considers C-Rad AB to be Fairly Valued.

Key valuation signals for LTS:0R44:

  • Valuation Rank:
  • GF Value™: kr33.52 vs. price of kr35.90 (7.1% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
91GF Score

Get the complete analysis for LTS:0R44

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.90
Price
kr33.52
GF Value